Eli Lilly | DŁUG



Debt Zmiana Data
AbbVie USD 67.14B 3.94B 2024-12
Abbott USD 14.98B 225M 2024-09
ALKERMES USD 0 366M 2024-12
Amgen USD 60.1B 299M 2024-12
AstraZeneca USD 30.3B 1.27B 2024-12
Baxter International USD 13.13B 191M 2024-12
Biogen USD 6.3B 1.9M 2024-12
Bristol-Myers Squibb USD 49.65B 103M 2024-12
Drreddys Laboratories INR 51.08B 2.55B 2024-12
Eli Lilly USD 33.64B 2.52B 2024-12
Gilead Sciences USD 26.71B 3.46B 2024-12
GlaxoSmithKline GBP 16.99B 927M 2024-12
Glaxosmithkline GBP 16.99B 927M 2024-12
Indivior 284M 3M 2024-09
J&J USD 36.63B 883M 2024-12
Medtronic USD 26.61B 1.72B 2025-01
Merck USD 37.11B 1.02B 2024-12
Neurocrine Biosciences USD 0 0 2024-12
Novartis USD 31.26B 828M 2024-12
Novartis USD 31.26B 828M 2024-12
Novo Nordisk 56.97B 88M 2024-09
Perrigo USD 3.62B 1.14B 2024-12
Pfizer USD 64.35B 3.35B 2024-12
Prestige Brands USD 996.95M 54.86M 2024-12
Regeneron Pharmaceuticals USD 2.7B 400K 2024-12
Roche Holding CHF 34.44B 5.23B 2024-06
Sanofi 23.75B 5.33B 2024-06
Sanofi 23.75B 5.33B 2024-06
United Therapeutics USD 300M 100M 2024-12
Zoetis USD 6.57B 4M 2024-12



Eli Lilly DŁUG - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Mar 2025.